Latest News
Instem Scientific’s Safety Intelligence Programme (SIP) now contains in-depth coverage of adverse effects on skin
SIP is a knowledgebase of toxicological and pathological adverse effects of drugs and other compounds. It contains deep coverage of biomedical observations (BMOs) occurring in many different tissues (e.g. liver, heart), and we can now add skin (including appendages such as hair and nail) to that list. The skin is an important organ, being the largest in [...]
Safety Intelligence Program Provides Insight into Drug-Induced Cardiac Effects
The Safety Intelligence Program (SIP) is a comprehensive knowledgebase of intelligence based around adverse effects of drugs and other compounds. It contains in-depth knowledge of drug effects in various tissues, including the cardiovascular system. Drug-induced cardiotoxicity Cardiotoxicity is a major adverse effect of drugs and has led to a number of withdrawals, for example terfenadine [...]
SIP Update: Drug-induced Renal Injury
The kidney is inherently prone to toxicity. It is highly vascularised, receiving ~25% of cardiac output, and as a consequence is especially vulnerable to drug-induced injury. Moreover, it is a primary site for the elimination of drugs, which further increases exposure of the kidney to potentially toxic substances. Drug-induced nephrotoxicity is common in clinical practice; [...]
Metawise Webinar: Turning Legacy Data into Actionable Intelligence
In this Webinar, Paul Bradley presents Metawise, a novel approach to terminology management that provides flexible and controllable terminology for search and identification of life science concepts from text sources.
 | Metawise Webinar - Turning Legacy Data into Actionable Intelligence |
Instem Life Science Systems Acquires BioWisdom Ltd.
We are very pleased to announce that at Instem Life Science Systems (http://www.instem-lss.com) has completed the acquisition of Biowisdom Limited. More details are available in the link below.
 |
Instem BioWisdom Acquisition |